Answers are grounded in this paper and cite their sources.
Under combined antiretroviral therapy (cART), HIV-1 continues to persist in macrophages. Better understanding of HIV-1 infection in macrophages may lead to new adjunctive therapies to improve cART, specifically targeting the viral reservoir and ameliorating tissue-specific diseases.
No takes yet. Share an insight, caveat, or question.
Cobos-Jiménez et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: